US Stock MarketDetailed Quotes

NBSE NeuBase Therapeutics

Watchlist
  • 0.3780
  • 0.00000.00%
Close May 10 16:00 ET
1.42MMarket Cap-55P/E (TTM)

NeuBase Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
(Q3)Jun 30, 2022
(Q2)Mar 31, 2022
(Q1)Dec 31, 2021
(FY)Sep 30, 2021
(Q4)Sep 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
77.53%-2M
55.52%-3.64M
-3.45M
-53.72%-29.01M
-21.97%-6.64M
-45.40%-8.91M
-132.70%-8.19M
-39.35%-5.27M
-76.22%-18.87M
-52.54%-5.44M
Net income from continuing operations
78.55%-1.82M
65.27%-3.45M
---4.09M
-32.93%-33.78M
-6.61%-7.63M
1.98%-8.49M
-79.73%-9.92M
-90.06%-7.73M
-46.16%-25.41M
-52.28%-7.16M
Operating gains losses
---800.68K
-18,732.78%-1.43M
--53.61K
143.35%427.22K
-92.50%11.44K
--0
97.95%-7.6K
171.79%423.37K
-236.89%-985.48K
137.10%152.64K
Depreciation and amortization
-23.87%250.25K
-27.08%303.98K
--300.47K
119.37%1.26M
31.87%335.46K
93.68%328.69K
400.44%416.87K
166.44%181.49K
105.20%575.52K
411.37%254.4K
Other non cash items
--660
----
----
----
----
----
----
--103.6K
--2.89M
--0
Change In working capital
85.88%-196.45K
-232.55%-627.13K
---25.57K
-50.97%177.07K
-61.79%136.32K
-42.99%-1.39M
-64.87%473.11K
359.53%958.71K
-24.65%361.16K
0.69%356.74K
-Change in prepaid assets
181.41%417.71K
-123.99%-276.31K
--233.81K
167.02%519.65K
155.71%278.86K
-113.02%-513.12K
-162.80%-123.36K
480.96%877.27K
-269.24%-775.31K
-355.67%-500.58K
-Change in payables and accrued expense
33.54%-495.26K
-132.72%-234.64K
---146.43K
-104.03%-49.95K
-100.66%-6.72K
5.75%-745.25K
-37.66%717.04K
89.21%-15.01K
5,740.95%1.24M
542.03%1.02M
-Change in other current assets
----
----
----
200.00%160.42K
--0
--0
--0
--160.42K
---160.42K
---160.42K
-Change in other current liabilities
10.40%-118.9K
3.63%-116.18K
---112.94K
-869.21%-453.06K
-151,010.00%-135.82K
-325.64%-132.7K
---120.56K
---63.97K
--58.9K
--90
Cash from discontinued investing activities
Operating cash flow
77.53%-2M
55.52%-3.64M
---3.45M
-53.72%-29.01M
-21.97%-6.64M
-45.40%-8.91M
-132.70%-8.19M
-39.35%-5.27M
-76.22%-18.87M
-52.54%-5.44M
Investing cash flow
Cash flow from continuing investing activities
0
0
-4.95K
81.60%-471.74K
91.81%-28.81K
90.49%-170.62K
29.11%-148.41K
40.58%-123.91K
-257.62%-2.56M
0.65%-351.62K
Net PPE purchase and sale
--0
--0
---4.95K
67.21%-471.71K
91.57%-28.81K
75.41%-170.62K
29.10%-148.41K
36.00%-123.88K
-100.67%-1.44M
3.47%-341.63K
Net business purchase and sale
----
----
----
--0
--0
----
----
----
---1.1M
--0
Net investment purchase and sale
----
----
----
99.88%-30
--0
--0
--0
99.80%-30
---25.01K
---9.99K
Cash from discontinued investing activities
Investing cash flow
--0
--0
---4.95K
81.60%-471.74K
91.81%-28.81K
90.49%-170.62K
29.11%-148.41K
40.58%-123.91K
-257.62%-2.56M
0.65%-351.62K
Financing cash flow
Cash flow from continuing financing activities
-531.79%-174.5K
16,862.95%4.55M
-88.42K
-100.61%-257.02K
82.42%-27.3K
-100.06%-27.62K
-27.12K
-570.12%-174.98K
27.89%42.34M
-1,333.23%-155.32K
Net issuance payments of debt
27.20%-20.11K
-9.54%-29.71K
---29.17K
-1,148.57%-109.5K
-220.73%-28.13K
---27.62K
---27.12K
---26.63K
---8.77K
---8.77K
Net common stock issuance
---158.2K
----
----
--0
--0
----
----
----
28.04%42.62M
--0
Proceeds from stock option exercised by employees
--3.81K
--0
--721
-99.23%868
--826
--0
--0
-99.96%42
-34.25%112.45K
--0
Net other financing activities
----
----
---59.97K
61.14%-148.39K
--0
--0
--0
-7.09%-148.39K
-9.15%-381.8K
19.42%-146.55K
Cash from discontinued financing activities
Financing cash flow
-531.79%-174.5K
16,862.95%4.55M
---88.42K
-100.61%-257.02K
82.42%-27.3K
-100.06%-27.62K
---27.12K
-570.12%-174.98K
27.89%42.34M
-1,333.23%-155.32K
Net cash flow
Beginning cash position
-62.15%14.75M
-70.75%13.85M
--17.39M
65.33%52.89M
-49.28%29.85M
60.67%38.96M
69.16%47.33M
65.33%52.89M
210.18%31.99M
63.79%58.84M
Current changes in cash
76.11%-2.18M
110.78%902.38K
---3.54M
-242.29%-29.74M
-12.52%-6.69M
-126.34%-9.11M
-124.34%-8.37M
-38.65%-5.57M
-3.59%20.9M
-51.28%-5.95M
End cash Position
-57.88%12.57M
-62.15%14.75M
--13.85M
-56.23%23.15M
-56.23%23.15M
-49.28%29.85M
60.67%38.96M
69.16%47.33M
65.33%52.89M
65.33%52.89M
Free cash flow
77.95%-2M
56.31%-3.64M
---3.46M
-45.15%-29.48M
-15.27%-6.67M
-33.12%-9.08M
-123.62%-8.34M
-35.68%-5.39M
-77.76%-20.31M
-47.48%-5.78M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Sep 30, 2022(Q4)Sep 30, 2022(Q3)Jun 30, 2022(Q2)Mar 31, 2022(Q1)Dec 31, 2021(FY)Sep 30, 2021(Q4)Sep 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 77.53%-2M55.52%-3.64M-3.45M-53.72%-29.01M-21.97%-6.64M-45.40%-8.91M-132.70%-8.19M-39.35%-5.27M-76.22%-18.87M-52.54%-5.44M
Net income from continuing operations 78.55%-1.82M65.27%-3.45M---4.09M-32.93%-33.78M-6.61%-7.63M1.98%-8.49M-79.73%-9.92M-90.06%-7.73M-46.16%-25.41M-52.28%-7.16M
Operating gains losses ---800.68K-18,732.78%-1.43M--53.61K143.35%427.22K-92.50%11.44K--097.95%-7.6K171.79%423.37K-236.89%-985.48K137.10%152.64K
Depreciation and amortization -23.87%250.25K-27.08%303.98K--300.47K119.37%1.26M31.87%335.46K93.68%328.69K400.44%416.87K166.44%181.49K105.20%575.52K411.37%254.4K
Other non cash items --660--------------------------103.6K--2.89M--0
Change In working capital 85.88%-196.45K-232.55%-627.13K---25.57K-50.97%177.07K-61.79%136.32K-42.99%-1.39M-64.87%473.11K359.53%958.71K-24.65%361.16K0.69%356.74K
-Change in prepaid assets 181.41%417.71K-123.99%-276.31K--233.81K167.02%519.65K155.71%278.86K-113.02%-513.12K-162.80%-123.36K480.96%877.27K-269.24%-775.31K-355.67%-500.58K
-Change in payables and accrued expense 33.54%-495.26K-132.72%-234.64K---146.43K-104.03%-49.95K-100.66%-6.72K5.75%-745.25K-37.66%717.04K89.21%-15.01K5,740.95%1.24M542.03%1.02M
-Change in other current assets ------------200.00%160.42K--0--0--0--160.42K---160.42K---160.42K
-Change in other current liabilities 10.40%-118.9K3.63%-116.18K---112.94K-869.21%-453.06K-151,010.00%-135.82K-325.64%-132.7K---120.56K---63.97K--58.9K--90
Cash from discontinued investing activities
Operating cash flow 77.53%-2M55.52%-3.64M---3.45M-53.72%-29.01M-21.97%-6.64M-45.40%-8.91M-132.70%-8.19M-39.35%-5.27M-76.22%-18.87M-52.54%-5.44M
Investing cash flow
Cash flow from continuing investing activities 00-4.95K81.60%-471.74K91.81%-28.81K90.49%-170.62K29.11%-148.41K40.58%-123.91K-257.62%-2.56M0.65%-351.62K
Net PPE purchase and sale --0--0---4.95K67.21%-471.71K91.57%-28.81K75.41%-170.62K29.10%-148.41K36.00%-123.88K-100.67%-1.44M3.47%-341.63K
Net business purchase and sale --------------0--0---------------1.1M--0
Net investment purchase and sale ------------99.88%-30--0--0--099.80%-30---25.01K---9.99K
Cash from discontinued investing activities
Investing cash flow --0--0---4.95K81.60%-471.74K91.81%-28.81K90.49%-170.62K29.11%-148.41K40.58%-123.91K-257.62%-2.56M0.65%-351.62K
Financing cash flow
Cash flow from continuing financing activities -531.79%-174.5K16,862.95%4.55M-88.42K-100.61%-257.02K82.42%-27.3K-100.06%-27.62K-27.12K-570.12%-174.98K27.89%42.34M-1,333.23%-155.32K
Net issuance payments of debt 27.20%-20.11K-9.54%-29.71K---29.17K-1,148.57%-109.5K-220.73%-28.13K---27.62K---27.12K---26.63K---8.77K---8.77K
Net common stock issuance ---158.2K----------0--0------------28.04%42.62M--0
Proceeds from stock option exercised by employees --3.81K--0--721-99.23%868--826--0--0-99.96%42-34.25%112.45K--0
Net other financing activities -----------59.97K61.14%-148.39K--0--0--0-7.09%-148.39K-9.15%-381.8K19.42%-146.55K
Cash from discontinued financing activities
Financing cash flow -531.79%-174.5K16,862.95%4.55M---88.42K-100.61%-257.02K82.42%-27.3K-100.06%-27.62K---27.12K-570.12%-174.98K27.89%42.34M-1,333.23%-155.32K
Net cash flow
Beginning cash position -62.15%14.75M-70.75%13.85M--17.39M65.33%52.89M-49.28%29.85M60.67%38.96M69.16%47.33M65.33%52.89M210.18%31.99M63.79%58.84M
Current changes in cash 76.11%-2.18M110.78%902.38K---3.54M-242.29%-29.74M-12.52%-6.69M-126.34%-9.11M-124.34%-8.37M-38.65%-5.57M-3.59%20.9M-51.28%-5.95M
End cash Position -57.88%12.57M-62.15%14.75M--13.85M-56.23%23.15M-56.23%23.15M-49.28%29.85M60.67%38.96M69.16%47.33M65.33%52.89M65.33%52.89M
Free cash flow 77.95%-2M56.31%-3.64M---3.46M-45.15%-29.48M-15.27%-6.67M-33.12%-9.08M-123.62%-8.34M-35.68%-5.39M-77.76%-20.31M-47.48%-5.78M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg